The abstract is read at the publisher; the summary is JClub's.
Indole-3-propionic acid (IPA) deficiency is linked to post-stroke cognitive impairment in patients and MCAO mice, and early IPA supplementation preserves dorsal hippocampal catecholamines.
- Why it matters: Gut dysbiosis is implicated in PSCI, but which microbiota-derived metabolites contribute and whether they can be therapeutically targeted remained unclear.
- What they did: The study compared gut microbes and circulating IPA in PSCI patients and MCAO mice, then tested exogenous IPA and assessed dorsal hippocampal tyrosine hydroxylase-positive fibers, catecholamine levels, and the Ywhab–ERK pathway.
- The result: IPA administration alleviated PSCI-like phenotypes in MCAO mice by preserving Th+ fibers and catecholamines; Ywhab knockdown reproduced protective effects, nominating Ywhab as a therapeutic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.